76 related articles for article (PubMed ID: 2117892)
21. Local recurrences and primary surgery in rectal carcinoma.
Di Matteo G; Maturo A; Redler A; D'Andrea V; Di Matteo FM; Montori J; Peparini N; Zeri KP; Mascagni D
Panminerva Med; 2000 Sep; 42(3):201-5. PubMed ID: 11218626
[TBL] [Abstract][Full Text] [Related]
22. [Hyperthermia in adjuvant therapy of locally advanced carcinoma of the rectum. Study protocol and initial clinical experience].
Civalleri D; De Cian F; Balletto N; De Paoli M; Mondini G; Esposito M
Minerva Chir; 1994 Jun; 49(6):539-51. PubMed ID: 7970058
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic analysis in intraperitoneal hyperthermic perfusion using mitomycin C in far-advanced gastric cancer].
Fujimoto S; Shrestha RD; Kokubun M; Kobayashi K; Kiuchi S; Ohta M; Takahashi M; Konno C; Koike S; Okui K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2411-5. PubMed ID: 2502075
[TBL] [Abstract][Full Text] [Related]
24. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.
Hildebrandt B; Wust P; Dräger J; Lüdemann L; Sreenivasa G; Tullius SG; Amthauer H; Neuhaus P; Felix R; Riess H
Int J Hyperthermia; 2004 Jun; 20(4):359-69. PubMed ID: 15204518
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant chemotherapy of colorectal cancer--results of prospective randomized trials].
Hojo K; Kajitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3063-73. PubMed ID: 3094459
[TBL] [Abstract][Full Text] [Related]
26. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
27. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
28. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
[TBL] [Abstract][Full Text] [Related]
29. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia.
Hildebrandt B; Wust P; Gellermann J; Nicolaou A; Trappe RU; Felix R; Riess H; Rau B
Onkologie; 2004 Oct; 27(5):506-11. PubMed ID: 15585984
[TBL] [Abstract][Full Text] [Related]
30. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
31. [Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
Kodaira S; Kikuchi K; Inokuchi K; Komi N; Hattori T; Taguchi T; Kondo T; Abe O; Uchino J; Ogawa N
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3399-408. PubMed ID: 2508566
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the oncologic outcome of laparoscopic surgery and open surgery for T1 and T2 rectosigmoidal and rectal carcinoma: matched case-control study.
Nakamura T; Kokuba Y; Mitomi H; Onozato W; Hatate K; Satoh T; Ozawa H; Ihara A; Watanabe M
Hepatogastroenterology; 2007 Jun; 54(76):1094-7. PubMed ID: 17629046
[TBL] [Abstract][Full Text] [Related]
33. Outcome after curative resection for locally recurrent rectal cancer.
Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
[TBL] [Abstract][Full Text] [Related]
34. Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer.
Hasdemir O; Cöl C; Yalçin E; Tunç G; Bilgen K; Kuçukpinar T
Hepatogastroenterology; 2005; 52(62):455-9. PubMed ID: 15816456
[TBL] [Abstract][Full Text] [Related]
35. [Lymphadenectomy and nerve sparing technique in radical surgery of rectal cancer].
Di Matteo G; Mascagni D; Peparini N; Di Matteo FM
Ann Ital Chir; 1996; 67(5):593-602. PubMed ID: 9036817
[TBL] [Abstract][Full Text] [Related]
36. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
37. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
38. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ;
J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
